2m 2m 2m 2m 2m 2m 2m
Arbutus Biopharm (ABUS)
NASDAQ
$4.77+$0.11 (+2.34%)
Price as of Jul 14, 2026 4:00 AM EDT- $948.2MMarket Cap
- 43.98%1-Year Change
- BiotechnologyIndustry
Arbutus Biopharm (ABUS)
$4.77+$0.11 (+2.34%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
MORGAN STANLEY | 13.11% | 25.9M | -811,296 (-3.13%) | Mar 31, 2026 |
TWO SEAS CAPITAL LP | 9.39% | 18.6M | +6.0M (+32.16%) | Mar 31, 2026 |
WHITEFORT CAPITAL MANAGEMENT, LP | 7.56% | 14.9M | +1.6M (+10.63%) | Mar 31, 2026 |
BLACKROCK, INC. | 6.56% | 13.0M | -85,915 (-0.66%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 6.55% | 12.9M | +718,695 (+5.56%) | Dec 31, 2024 |
BLACKROCK INC. | 5.85% | 11.6M | +1.1M (+9.93%) | Jun 30, 2024 |
VANGUARD GROUP INC | 4.68% | 9.2M | +251,355 (+2.72%) | Dec 31, 2025 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.31% | 6.5M | +81,812 (+1.25%) | Mar 31, 2026 |
Morgan Stanley Insight Fund | 1.94% | 3.8M | -101,834 (-2.66%) | Mar 31, 2026 |
SPDR SERIES TRUST | 1.47% | 2.9M | 0 (0.00%) | Apr 30, 2026 |
MORGAN STANLEY INSTITUTIONAL FUND INC | 1.19% | 2.3M | -249,736 (-10.66%) | Mar 31, 2026 |
EQ ADVISORS TRUST | 0.86% | 1.7M | -21,961 (-1.30%) | Mar 31, 2026 |
VANGUARD SCOTTSDALE FUNDS | 0.46% | 903,143 | +19,821 (+2.19%) | Feb 28, 2026 |
SCHWAB STRATEGIC TRUST | 0.42% | 831,378 | +8,240 (+0.99%) | Feb 28, 2026 |
Current Ownership Distribution
- Institutions1.5B (80.74%)
- Mutual Funds260.4M (13.88%)
- Insiders100.9M (5.38%)
- Other0 (0.00%)
Insider Transactions
- 5.38% (100.9M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Sawhney Roger | Award | Jun 08, 2026 | $0.00 | 78,800 | $0.00 | 78,800 |
Beardsley Robert A | Award | Jun 08, 2026 | $0.00 | 78,800 | $0.00 | 78,800 |
Androski Lindsay President and CEO | Award | Feb 02, 2026 | $0.00 | 71,700 | $0.00 | 71,700 |
Nguyen Tuan Chief Financial Officer | Award | Feb 02, 2026 | $0.00 | 188,400 | $0.00 | 188,400 |
Androski Lindsay President and CEO | Award | Feb 02, 2026 | $0.00 | 28,000 | $0.00 | 28,000 |
Nguyen Tuan Chief Financial Officer | Award | Feb 02, 2026 | $0.00 | 73,500 | $0.00 | 73,500 |
Sawhney Roger | Award | Aug 04, 2025 | $0.00 | 157,600 | $0.00 | 157,600 |
Nguyen Tuan Chief Financial Officer | Award | Mar 31, 2025 | $0.00 | 750,000 | $0.00 | 750,000 |
Nguyen Tuan Chief Financial Officer | Award | Mar 31, 2025 | $0.00 | 750,000 | $0.00 | 750,000 |
Beardsley Robert A | Award | Mar 18, 2025 | $0.00 | 157,600 | $0.00 | 157,600 |
Hasija Anuj | Award | Mar 18, 2025 | $0.00 | 157,600 | $0.00 | 157,600 |
Sims Karen Chief Medical Officer | Award | Feb 14, 2025 | $0.00 | 200,300 | $0.00 | 200,300 |
Naftzger J. Christopher General Counsel and CCO | Award | Feb 14, 2025 | $0.00 | 220,300 | $0.00 | 220,300 |
McElhaugh Michael J. Interim President & CEO | Award | Feb 14, 2025 | $0.00 | 718,800 | $0.00 | 718,800 |
HASTINGS DAVID C Chief Financial Officer | Award | Feb 14, 2025 | $0.00 | 365,800 | $0.00 | 365,800 |
Sims Karen Chief Medical Officer | Award | Feb 14, 2025 | $0.00 | 49,300 | $0.00 | 155,494 |
Naftzger J. Christopher General Counsel and CCO | Award | Feb 14, 2025 | $0.00 | 54,300 | $0.00 | 140,544 |
McElhaugh Michael J. Interim President & CEO | Award | Feb 14, 2025 | $0.00 | 177,000 | $0.00 | 1.7M |
HASTINGS DAVID C Chief Financial Officer | Award | Feb 14, 2025 | $0.00 | 90,100 | $0.00 | 249,824 |
McElhaugh Michael J. Interim President & CEO | Sell | Feb 04, 2025 | $78,102.57 | 23,790 | $3.28 | 1.5M |
HASTINGS DAVID C Chief Financial Officer | Sell | Feb 04, 2025 | $72,826.79 | 22,183 | $3.28 | 159,724 |
Naftzger J. Christopher General Counsel and CCO | Sell | Feb 04, 2025 | $37,206.24 | 11,333 | $3.28 | 86,244 |
Sims Karen Chief Medical Officer | Sell | Feb 04, 2025 | $63,519.48 | 19,348 | $3.28 | 106,194 |